Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

26.70
Delayed Data
As of Oct 19
 -0.35 / -1.29%
Today’s Change
13.60
Today|||52-Week Range
33.00
+42.02%
Year-to-Date

Today’s Trading

Previous close27.05
Today’s open26.75
Day’s range26.35 - 27.10
Volume464,373
Average volume (3 months)798,718
Market cap$1.3B
Dividend yield--
Data as of 10/19/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+540.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.12-0.62%
ATNXAthenex Inc-0.06-0.35%
DERMDermira Inc+0.68+2.42%
CLLSCellectis SA+0.28+1.02%
Data as of 10/19/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts